Cardiology Devices - South America

  • South America
  • The Cardiology Devices market market in South America is anticipated to witness a substantial growth in revenue, with projected figures reaching US$3.69bn by the year 2024.
  • This growth is expected to continue with an annual growth rate (CAGR 2024-2029) of 7.22%, leading to a market volume of US$5.23bn by 2029.
  • In comparison to other countries around Worldwide, the United States is predicted to generate the highest revenue in the Cardiology Devices market market, with an estimated amount of US$25,770.00m in 2024.
  • South America is experiencing a growing demand for advanced cardiology devices, driven by increasing awareness of cardiovascular diseases and improving healthcare infrastructure.

Key regions: United Kingdom, United States, France, Spain, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cardiology Devices market in South America is experiencing steady growth due to increasing customer preferences for advanced medical technologies and the rising incidence of cardiovascular diseases in the region.

Customer preferences:
Customers in South America are increasingly seeking advanced cardiology devices that offer accurate diagnosis and effective treatment options. They prefer devices that are minimally invasive, provide real-time monitoring, and offer improved patient outcomes. In addition, there is a growing demand for portable and wearable cardiology devices that allow patients to monitor their health on the go.

Trends in the market:
One of the key trends in the South American Cardiology Devices market is the increasing adoption of implantable cardiac devices such as pacemakers and implantable cardioverter-defibrillators (ICDs). These devices are used to regulate heart rhythms and prevent sudden cardiac arrest. The demand for these devices is driven by the rising prevalence of cardiovascular diseases, particularly among the aging population. Another trend in the market is the growing use of interventional cardiology devices such as stents and catheters. These devices are used in minimally invasive procedures to open blocked arteries and restore blood flow to the heart. The demand for interventional cardiology devices is driven by the increasing incidence of coronary artery disease and the need for less invasive treatment options.

Local special circumstances:
South America has a high prevalence of cardiovascular diseases, including hypertension, coronary artery disease, and heart failure. This is primarily due to factors such as sedentary lifestyles, unhealthy diets, and limited access to healthcare services in certain regions. As a result, there is a growing need for advanced cardiology devices that can help diagnose and treat these conditions effectively.

Underlying macroeconomic factors:
The South American economy has been experiencing steady growth, which has resulted in increased healthcare spending. Governments in the region are investing in the development of healthcare infrastructure and the procurement of advanced medical technologies, including cardiology devices. This has created a favorable market environment for manufacturers and suppliers of cardiology devices. In conclusion, the Cardiology Devices market in South America is witnessing growth due to increasing customer preferences for advanced medical technologies, rising incidence of cardiovascular diseases, and favorable macroeconomic factors. The market is characterized by the adoption of implantable cardiac devices and interventional cardiology devices, driven by the need for accurate diagnosis and less invasive treatment options. However, local special circumstances such as the high prevalence of cardiovascular diseases and limited access to healthcare services pose challenges that need to be addressed in order to ensure the continued growth of the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)